콘텐츠로 건너뛰기
Merck
  • Glycosylation characterization of therapeutic mAbs by top- and middle-down mass spectrometry.

Glycosylation characterization of therapeutic mAbs by top- and middle-down mass spectrometry.

Data in brief (2016-01-23)
Bao Quoc Tran, Christopher Barton, Jinhua Feng, Aimee Sandjong, Sung Hwan Yoon, Shivangi Awasthi, Tao Liang, Mohd M Khan, David P A Kilgour, David R Goodlett, Young Ah Goo
초록

A reference monoclonal antibody IgG1 and a fusion IgG protein were analyzed by top- and middle-down mass spectrometry with multiple fragmentation techniques including electron transfer dissociation (ETD) and matrix-assisted laser desorption ionization in-source decay (MALDI-ISD) to investigate heterogeneity of glycosylated protein species. Specifically, glycan structure, sites, relative abundance levels, and termini structural conformation were investigated by use of Fourier transform ion cyclotron resonance (FT-ICR) or high performance liquid chromatography electrospray ionization (HPLC-ESI) linked to an Orbitrap. Incorporating a limited enzymatic digestion by immunoglobulin G-degrading enzyme Streptococcus pyogenes (IdeS) with MALDI-ISD analysis extended sequence coverage of the internal region of the proteins without pre-fractionation. The data in this article is associated with the research article published in Journal of Proteomics (Tran et al., 2015) [1].

MATERIALS
제품 번호
브랜드
제품 설명

Millipore
Amicon® Ultra Centrifugal Filter, 10 kDa MWCO, sample volume 2 mL, regenerated cellulose membrane, MWCO 10 kDa